E-ISSN: 1308-5263
Cutaneous Anaplastic Large-Cell Lymphoma with Dramatic Response to Brentuximab Vedotin [Turk J Hematol]
Turk J Hematol. 2021; 38(1): 85-87 | DOI: 10.4274/tjh.galenos.2020.2020.0512  

Cutaneous Anaplastic Large-Cell Lymphoma with Dramatic Response to Brentuximab Vedotin

Mustafa Şahin1, Mine Miskioğlu2, Işıl İnanır3, Hikmet Akar1, Nalan Neşe4, Peyker Temiz4, İsmet Aydoğdu2
1Celal Bayar University Faculty of Medicine, Department of Internal Medicine, Manisa, Turkey
2Celal Bayar University School of Medicine, Department of Hematology, Manisa, Turkey
3Celal Bayar University Faculty of Medicine, Department of Dermatology, Manisa, Turkey
4Celal Bayar University Faculty of Medicine, Department of Patology, Manisa, Turkey

Keywords: Cutaneous anaplastic large cell lymphoma, Brentuximab, Monotherapy, Breast cancer


Brentuximab Vedotine Dramatik Yanıtlı Kutanöz Anaplastik Büyük Hücreli Lenfoma

Mustafa Şahin1, Mine Miskioğlu2, Işıl İnanır3, Hikmet Akar1, Nalan Neşe4, Peyker Temiz4, İsmet Aydoğdu2
1Celal Bayar University Faculty of Medicine, Department of Internal Medicine, Manisa, Turkey
2Celal Bayar University Faculty of Medicine, Department of Hematology, Manisa, Turkey
3Celal Bayar University Faculty of Medicine, Department of Dermatology, Manisa, Turkey
4Celal Bayar University Faculty of Medicine, Department of Patology, Manisa, Turkey

Anahtar Kelimeler: Kutanöz anaplastik büyük hücreli lenfoma, Brentuximab, Monoterapi, Meme kanseri


Mustafa Şahin, Mine Miskioğlu, Işıl İnanır, Hikmet Akar, Nalan Neşe, Peyker Temiz, İsmet Aydoğdu. Cutaneous Anaplastic Large-Cell Lymphoma with Dramatic Response to Brentuximab Vedotin. Turk J Hematol. 2021; 38(1): 85-87

Corresponding Author: Mustafa Şahin, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar


 



Impact Factor (2019) = 1.685